• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨基糖苷类-氨基环醇类药物对分枝杆菌的体外活性

In-vitro activities of aminoglycoside-aminocyclitols against mycobacteria.

作者信息

Ho Y I, Chan C Y, Cheng A F

机构信息

Department of Microbiology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin NT.

出版信息

J Antimicrob Chemother. 1997 Jul;40(1):27-32. doi: 10.1093/jac/40.1.27.

DOI:10.1093/jac/40.1.27
PMID:9249201
Abstract

Aminoglycoside-aminocyclitols including streptomycin, kanamycin, capreomycin and amikacin showed considerable activity against Mycobacterium tuberculosis, with MICs well below their Cmax and relatively low MBC/MIC ratios. Kanamycin, capreomycin and amikacin remained highly active against 'resistant' and 'multidrug-resistant' M. tuberculosis isolates except for some 'multidrug-resistant' isolates which showed complete cross-resistance between streptomycin and the selected 2-deoxystreptamines. Gentamicin displayed anti-tuberculous activity but was bacteriostatic only. Non-tuberculosis mycobacteria, in particular Mycobacterium chelonae and Mycobacterium avium-intracellulare, were more resistant than M. tuberculosis. Amikacin was inhibitory against Mycobacterium kanasii, Mycobacterium scrofulaceum and Mycobacterium fortuitum, but was bactericidal against M. scrofulaceum only. Kanamycin was also bactericidal against M. scrofulaceum. Growth of M. fortuitum was inhibited by amikacin and neomycin which was also inhibitory against M. tuberculosis and M. scrofulaceum. Although the application of neomycin has been limited by its high toxicity, this study suggested that this drug might be useful as a topical agent for cutaneous infections by M. fortuitum.

摘要

包括链霉素、卡那霉素、卷曲霉素和阿米卡星在内的氨基糖苷类氨基环醇类药物对结核分枝杆菌显示出相当强的活性,其最低抑菌浓度(MIC)远低于其血药浓度峰值(Cmax),且最低杀菌浓度与最低抑菌浓度之比(MBC/MIC)相对较低。卡那霉素、卷曲霉素和阿米卡星对“耐药”和“耐多药”结核分枝杆菌分离株仍保持高度活性,但某些“耐多药”分离株除外,这些分离株在链霉素和所选的2-脱氧链霉胺之间表现出完全交叉耐药。庆大霉素显示出抗结核活性,但仅具有抑菌作用。非结核分枝杆菌,尤其是龟分枝杆菌和鸟分枝杆菌复合群,比结核分枝杆菌更具耐药性。阿米卡星对堪萨斯分枝杆菌、瘰疬分枝杆菌和偶然分枝杆菌有抑制作用,但仅对瘰疬分枝杆菌有杀菌作用。卡那霉素对瘰疬分枝杆菌也有杀菌作用。阿米卡星和新霉素可抑制偶然分枝杆菌的生长,新霉素对结核分枝杆菌和瘰疬分枝杆菌也有抑制作用。尽管新霉素因其高毒性而应用受限,但本研究表明该药物可能作为治疗偶然分枝杆菌皮肤感染的外用药物。

相似文献

1
In-vitro activities of aminoglycoside-aminocyclitols against mycobacteria.氨基糖苷类-氨基环醇类药物对分枝杆菌的体外活性
J Antimicrob Chemother. 1997 Jul;40(1):27-32. doi: 10.1093/jac/40.1.27.
2
Comparison of bactericidal activities of streptomycin, amikacin, kanamycin, and capreomycin against Mycobacterium avium and M. tuberculosis.链霉素、阿米卡星、卡那霉素和卷曲霉素对鸟分枝杆菌和结核分枝杆菌杀菌活性的比较。
Antimicrob Agents Chemother. 1989 Aug;33(8):1298-301. doi: 10.1128/AAC.33.8.1298.
3
Comparative evaluation of the in vitro antimycobacterial activities of six aminoglycoside antibiotics using an agar dilution method.使用琼脂稀释法对六种氨基糖苷类抗生素的体外抗分枝杆菌活性进行比较评估。
J Chemother. 2006 Dec;18(6):610-6. doi: 10.1179/joc.2006.18.6.610.
4
Susceptibility of Mycobacterium tuberculosis to Amikacin, Kanamycin, and Capreomycin.结核分枝杆菌对阿米卡星、卡那霉素和卷曲霉素的敏感性。
Antimicrob Agents Chemother. 2018 Feb 23;62(3). doi: 10.1128/AAC.01724-17. Print 2018 Mar.
5
Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables.将结核分枝杆菌临床分离株中rrs和eis启动子突变与对二线注射剂的表型药敏水平相关联。
Int J Mycobacteriol. 2016 Mar;5(1):1-6. doi: 10.1016/j.ijmyco.2015.09.001. Epub 2015 Oct 1.
6
Comparison of clinical isolates and in vitro selected mutants reveals that tlyA is not a sensitive genetic marker for capreomycin resistance in Mycobacterium tuberculosis.临床分离株与体外筛选突变株的比较表明,tlyA 不是结核分枝杆菌卷曲霉素耐药的敏感遗传标记。
J Antimicrob Chemother. 2011 Jun;66(6):1247-54. doi: 10.1093/jac/dkr109. Epub 2011 Mar 21.
7
In Vitro activities of isepamicin, other aminoglycosides, and capreomycin against clinical isolates of rapidly growing mycobacteria in Taiwan.异帕米星、其他氨基糖苷类药物及卷曲霉素对台湾快速生长分枝杆菌临床分离株的体外活性
Antimicrob Agents Chemother. 2007 May;51(5):1849-51. doi: 10.1128/AAC.01551-06. Epub 2007 Mar 12.
8
High efficacy of clofazimine and its synergistic effect with amikacin against rapidly growing mycobacteria.氯法齐明的高效性及其与阿米卡星的协同作用对快速生长分枝杆菌。
Int J Antimicrob Agents. 2010 Apr;35(4):400-4. doi: 10.1016/j.ijantimicag.2009.12.008.
9
Activity of amikacin against Mycobacteria in vitro and in murine tuberculosis.
Tubercle. 1982 Sep;63(3):201-8. doi: 10.1016/s0041-3879(82)80031-7.
10
Amikacin in the treatment of pulmonary tuberculosis.阿米卡星治疗肺结核。
Tubercle. 1983 Jun;64(2):111-8. doi: 10.1016/0041-3879(83)90035-1.

引用本文的文献

1
Synthesis and anti-mycobacterial activity of novel medium-chain β-lactone derivatives: a multi-target strategy to combat .新型中链β-内酯衍生物的合成及其抗分枝杆菌活性:一种对抗……的多靶点策略
RSC Med Chem. 2025 Apr 25. doi: 10.1039/d5md00102a.
2
Risk of tuberculosis transmission by tissue transplantation: a quantitative risk assessment.组织移植导致结核病传播的风险:一项定量风险评估。
Cell Tissue Bank. 2025 Apr 4;26(2):21. doi: 10.1007/s10561-025-10168-1.
3
Preclinical Evaluation of Inhalational Spectinamide-1599 Therapy against Tuberculosis.
吸入用spectinamide-1599 治疗结核病的临床前评价。
ACS Infect Dis. 2021 Oct 8;7(10):2850-2863. doi: 10.1021/acsinfecdis.1c00213. Epub 2021 Sep 21.
4
Lesion Penetration and Activity Limit the Utility of Second-Line Injectable Agents in Pulmonary Tuberculosis.病变穿透和活动度限制了二线注射用药物在肺结核中的应用。
Antimicrob Agents Chemother. 2021 Sep 17;65(10):e0050621. doi: 10.1128/AAC.00506-21. Epub 2021 Jul 12.
5
NOD: a web server to predict New use of Old Drugs to facilitate drug repurposing.NOD:一个用于预测旧药新用途的网络服务器,以促进药物再利用。
Sci Rep. 2021 Jun 29;11(1):13540. doi: 10.1038/s41598-021-92903-8.
6
A GC-Rich Prophage-Like Genomic Region of Mycoplasma bovirhinis HAZ141_2 Carries a Gene Cluster Encoding Resistance to Kanamycin and Neomycin.牛支原体 HAZ141_2 中的一个富含 GC 的类噬菌体基因组区域携带一个编码对卡那霉素和新霉素抗性的基因簇。
Antimicrob Agents Chemother. 2021 Jan 20;65(2). doi: 10.1128/AAC.01010-20.
7
Susceptibility of Mycobacterium tuberculosis to Amikacin, Kanamycin, and Capreomycin.结核分枝杆菌对阿米卡星、卡那霉素和卷曲霉素的敏感性。
Antimicrob Agents Chemother. 2018 Feb 23;62(3). doi: 10.1128/AAC.01724-17. Print 2018 Mar.
8
Reduced Chance of Hearing Loss Associated with Therapeutic Drug Monitoring of Aminoglycosides in the Treatment of Multidrug-Resistant Tuberculosis.在耐多药结核病治疗中,氨基糖苷类药物治疗药物监测与听力损失几率降低相关。
Antimicrob Agents Chemother. 2017 Feb 23;61(3). doi: 10.1128/AAC.01400-16. Print 2017 Mar.
9
Aminoglycosides: An Overview.氨基糖苷类药物:概述
Cold Spring Harb Perspect Med. 2016 Jun 1;6(6):a027029. doi: 10.1101/cshperspect.a027029.
10
A Flow Cytometry Method for Rapidly Assessing Mycobacterium tuberculosis Responses to Antibiotics with Different Modes of Action.一种用于快速评估结核分枝杆菌对不同作用方式抗生素反应的流式细胞术方法。
Antimicrob Agents Chemother. 2016 Jun 20;60(7):3869-83. doi: 10.1128/AAC.02712-15. Print 2016 Jul.